HerAtrial.com

Title

Welcome to HERA Trial

Description

Gives details about the clinical trial involving the use of Herceptin as adjuvant therapy in HER2-positive patients with primary breast cancer. This resource is designed for use by patients and investigators.

Contact

F.Hoffmann-La Roche AG
Basel
Switzerland 4070
+41.616881148

Additional Information

Related Domains



Retrieved from "http://aboutus.com/index.php?title=HerAtrial.com&oldid=13705700"